Voluntary medical male circumcision (VMMC) for prevention of heterosexual transmission of HIV and risk compensation in adult males in Soweto: Findings from a programmatic setting.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
04
12
2017
accepted:
25
02
2019
entrez:
8
3
2019
pubmed:
8
3
2019
medline:
4
12
2019
Statut:
epublish
Résumé
Clinical trials have clearly shown a reduction in HIV acquisition through voluntary medical male circumcision (VMMC). However, data assessing risk compensation under programmatic conditions is limited. This was a prospective cohort of HIV seronegative males aged 18-40 years receiving VMMC between November 2012 and July 2014. HIV serostatus was determined pre and post VMMC. Risk compensation was defined as a decrease in condom use at last sex act and/or an increase in concurrent sexual relationships, both measured twelve months post-circumcision. A total of 233 males were enrolled and underwent voluntary medical male circumcision (VMMC) for prevention against HIV. There was no evidence of risk compensation post-circumcision as defined in this study. Significant increases in proportion of participants in the 18-24 years age group who knew the HIV status of their sexual partner (39% to 56%, p = 0.0019), self-reported condom use at last sex act (21% to 34%, p = 0.0106) and those reporting vaginal sexual intercourse in the past 12 months (67% to 79%, p-value = <0.0001) were found. In both 18-24 and 25-40 years age groups, there was a significant increase in perception of being at risk of contracting HIV (70% to 84%, p-value = <0.0001). No significant risk compensation was observed in this study on comparing pre-and post-circumcision behaviour. An increase in proportion of participants in the 18-24 years age group who had vaginal intercourse in the first 12 months post-circumcision as a possibility of risk compensation was minimal and negated by an increase in proportion of those reporting using a condom at the last sex act, increase in knowledge of partner's HIV status and lack of increase in alcohol post-circumcision.
Sections du résumé
BACKGROUND
Clinical trials have clearly shown a reduction in HIV acquisition through voluntary medical male circumcision (VMMC). However, data assessing risk compensation under programmatic conditions is limited.
METHODS
This was a prospective cohort of HIV seronegative males aged 18-40 years receiving VMMC between November 2012 and July 2014. HIV serostatus was determined pre and post VMMC. Risk compensation was defined as a decrease in condom use at last sex act and/or an increase in concurrent sexual relationships, both measured twelve months post-circumcision.
RESULTS
A total of 233 males were enrolled and underwent voluntary medical male circumcision (VMMC) for prevention against HIV. There was no evidence of risk compensation post-circumcision as defined in this study. Significant increases in proportion of participants in the 18-24 years age group who knew the HIV status of their sexual partner (39% to 56%, p = 0.0019), self-reported condom use at last sex act (21% to 34%, p = 0.0106) and those reporting vaginal sexual intercourse in the past 12 months (67% to 79%, p-value = <0.0001) were found. In both 18-24 and 25-40 years age groups, there was a significant increase in perception of being at risk of contracting HIV (70% to 84%, p-value = <0.0001).
CONCLUSION
No significant risk compensation was observed in this study on comparing pre-and post-circumcision behaviour. An increase in proportion of participants in the 18-24 years age group who had vaginal intercourse in the first 12 months post-circumcision as a possibility of risk compensation was minimal and negated by an increase in proportion of those reporting using a condom at the last sex act, increase in knowledge of partner's HIV status and lack of increase in alcohol post-circumcision.
Identifiants
pubmed: 30845185
doi: 10.1371/journal.pone.0213571
pii: PONE-D-17-42362
pmc: PMC6405100
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0213571Subventions
Organisme : FIC NIH HHS
ID : U2R TW007370
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Am J Public Health. 2007 Jul;97(7):1241-8
pubmed: 17538062
PLoS One. 2010 Dec 16;5(12):e15552
pubmed: 21179493
Afr J AIDS Res. 2016;15(1):67-75
pubmed: 27002359
AIDS Behav. 2014 Sep;18(9):1764-75
pubmed: 25047688
PLoS One. 2007 Oct 03;2(10):e1001
pubmed: 17912340
PLoS One. 2010 Aug 25;5(8):e12366
pubmed: 20811622
J Acquir Immune Defic Syndr. 2017 Feb 1;74(2):e30-e37
pubmed: 27632232
AIDS. 2010 Oct;24 Suppl 4:S61-9
pubmed: 21042054
Curr HIV/AIDS Rep. 2007 Dec;4(4):165-72
pubmed: 18366947
Cult Health Sex. 2015;17(7):920-31
pubmed: 25567140
PLoS One. 2008 Jun 18;3(6):e2443
pubmed: 18560581
Lancet. 2004 Jul 3-9;364(9428):4-6
pubmed: 15234834
HIV Med. 2008 Jul;9(6):332-5
pubmed: 18705758
BMJ. 2001 Jun 23;322(7301):1533-5
pubmed: 11420278